Related Experiment Video
Updated: May 11, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The Prognostic Value of Circulating Cytokines and Complete Blood Count-Based Inflammatory Markers in COVID-19
Giorgi Tcholadze1, Ia Pantsulaia1,2, Levan Ratiani3
1Department of Immunology, Tbilisi State Medical University, Tbilisi 0177, Georgia.
Insights
Elevated inflammatory markers like interleukin-6 (IL-6) predict severe COVID-19 in atrial fibrillation (AF) patients. This suggests using anti-inflammatory drugs for better outcomes in COVID-19 patients with arrhythmias.
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarkers
Background:
- Atrial fibrillation (AF) exacerbates cardiovascular disease burden, particularly during the COVID-19 pandemic.
- Inflammatory markers, including interleukin-6 (IL-6), are implicated in disease severity.
Purpose of the Study:
- To assess the association between clinical and inflammatory markers, specifically IL-6, and COVID-19 severity in patients with AF.
Main Methods:
- Retrospective cohort study of 100 hospitalized COVID-19 patients (40-80 years) with AF.
- Patients categorized by disease severity using CT scores, symptoms, respiratory rate, and oxygen saturation.
- Measured IL-6, C-reactive protein (CRP), ferritin, and D-dimer levels at multiple time points.
Main Results:
- AF patients showed significantly higher IL-6, CRP, ferritin, and D-dimer levels.
- Lower oxygen saturation and higher CT scores were observed in AF patients.
- AF patients experienced longer hospitalizations, indicating a more severe disease course.
Conclusions:
- Interleukin-6 (IL-6) is an independent predictor of COVID-19 severity in AF patients.
- Highlights the need for anti-inflammatory treatments for COVID-19 patients with arrhythmias.
- Biomarker integration aids in risk identification and patient management.
Background:
Atrial fibrillation (AF) is associated with a high burden of cardiovascular disease, which has been worsened during the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this study was to assess the association between clinical markers, especially interleukin-6 (IL-6) and other inflammatory biomarkers, and the severity of COVID-19 in patients with AF.
Methods:
This retrospective cohort study categorized patients based on clinical presentations and laboratory results to investigate the prognostic significance of inflammatory markers in COVID-19 outcomes among those with AF. The study included 100 hospitalized COVID-19 patients aged between 40 to 80 years and was conducted at the Chapidze Hospital in Tbilisi, Georgia. Patients were then grouped by disease severity according to computed tomography (CT) scores, clinical symptoms, respiratory rate and oxygen saturation. Levels of IL-6 were obtained at three time points during hospitalization. A broad range of laboratory tests, including C-reactive protein (CRP), ferritin, and D-dimer, were also conducted.
Results:
Patients with AF demonstrated significantly elevated levels of IL-6 (P = 0.024), CRP (P = 0.001), and ferritin (P < 0.001), suggesting a severe inflammatory response. D-dimer levels were also notably higher in the AF group (P < 0.005), indicating an increased risk of thrombotic complications. Oxygen saturation levels were significantly lower (P = 0.004) and CT scores higher in patients with AF. Furthermore, the length of hospitalization was longer among patients with AF (median duration significantly higher, P = 0.032), indicating a more severe disease course.
Conclusions:
The proinflammatory markers such as IL-6 are independent predictive markers of COVID-19 severity in AF patients. Overall, it highlights urgent treatment approaches, such as available anti-inflammatory drugs, for COVID-19 patients with arrhythmias. Combining these biomarkers into clinical routines helps us better identify patients at risk and how to treat them.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...